Glycoengineered hepatitis B virus-like particles with enhanced immunogenicity
- 10 April 2020
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 38 (22), 3892-3901
- https://doi.org/10.1016/j.vaccine.2020.03.007
Abstract
No abstract availableFunding Information
- RMIT University
- CSIRO
- Australian Centre for HIV and Viral Hepatitis Research
- Macquarie University Research Seeding
- International Macquarie University Research Excellence Scholarship (2017152)
This publication has 57 references indexed in Scilit:
- A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan ShieldScience, 2011
- Glycosylation Patterns of HIV-1 gp120 Depend on the Type of Expressing Cells and Affect Antibody RecognitionOnline Journal of Public Health Informatics, 2010
- Maintenance of cell surface glycan density by lectin-glycan interactions: A homeostatic and innate immune regulatory mechanismGlycobiology, 2010
- Lectins as pattern recognition molecules: The effects of epitope density in innate immunityGlycobiology, 2009
- Effect of the strength of adsorption of hepatitis B surface antigen to aluminum hydroxide adjuvant on the immune responseVaccine, 2009
- Nanoparticles target distinct dendritic cell populations according to their sizeEuropean Journal of Immunology, 2008
- The Common Vaccine Adjuvant Aluminum Hydroxide Up-Regulates Accessory Properties of Human Monocytes via an Interleukin-4-Dependent MechanismInfection and Immunity, 2001
- The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cellsEuropean Journal of Immunology, 1997
- Analysis of intermolecular disulfide bonds and free sulfhydryl groups in hepatitis B surface antigen particlesArchiv für die gesamte Virusforschung, 1997
- The structure of hepatitis B surface antigen and its antigenic sitesBioEssays, 1987